Envestnet Portfolio Solutions Inc. Sells 186 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Envestnet Portfolio Solutions Inc. trimmed its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 3,498 shares of the company’s stock after selling 186 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in HealthEquity were worth $232,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of HQY. Vontobel Holding Ltd. raised its position in HealthEquity by 96.3% in the fourth quarter. Vontobel Holding Ltd. now owns 73,564 shares of the company’s stock valued at $4,877,000 after purchasing an additional 36,085 shares during the last quarter. Mackenzie Financial Corp raised its position in HealthEquity by 58.2% in the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after purchasing an additional 664,979 shares during the last quarter. Comerica Bank increased its stake in shares of HealthEquity by 82,280.3% in the third quarter. Comerica Bank now owns 58,490 shares of the company’s stock valued at $4,273,000 after buying an additional 58,419 shares during the period. Natixis Advisors L.P. increased its stake in shares of HealthEquity by 7.2% in the third quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock valued at $1,290,000 after buying an additional 1,180 shares during the period. Finally, Gotham Asset Management LLC acquired a new stake in shares of HealthEquity in the third quarter valued at about $1,103,000. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HQY shares. JMP Securities started coverage on HealthEquity in a research note on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price target for the company. Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of HealthEquity in a research note on Friday, March 22nd. Royal Bank of Canada increased their price target on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, March 20th. KeyCorp increased their price target on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. Finally, BTIG Research increased their price target on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $96.17.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 2,558 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares in the company, valued at $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Delano Ladd sold 2,558 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares in the company, valued at $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,823 shares of company stock worth $5,482,975. Corporate insiders own 2.70% of the company’s stock.

HealthEquity Stock Down 0.7 %

Shares of NASDAQ:HQY opened at $79.27 on Friday. The business’s 50 day simple moving average is $79.77 and its two-hundred day simple moving average is $75.47. The firm has a market cap of $6.90 billion, a P/E ratio of 123.86, a PEG ratio of 1.17 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. HealthEquity, Inc. has a 52-week low of $54.09 and a 52-week high of $84.49.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. The business had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. As a group, research analysts forecast that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.